Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Exact Sciences Corp (EXAS): D. E. Shaw Boosts Stake In High-Flying Stock

David E. Shaw‘s fund, D E Shaw, has increased its investment in Exact Sciences Corp (NASDAQ:EXAS), as reported in a recent filing with the Securities and Exchange Commission. The fund now holds a little over 4.9 million shares, which amount to approximately 5% of the company’s common stock, up from 3.28 million shares it reported at the end of the first quarter.

A developer of products for early detection of various forms of cancer, Exact Sciences Corp (NASDAQ:EXAS) has a market cap of $1.78 billion and does not pay a dividend. So far this year, the stock has managed to advance by 102%, although it was dormant up until mid-June when the rally actually begun. Analysts at Canaccord Genuity raised their price target on June 14 after the U.S. Preventive Services Task Force had issued a recommendation statement that underlined the potential of the company’s technology.

The stock received another boost on July 26, when Exact Sciences reported second-quarter financial results that surpassed market’s expectations. The company posted $21.2 million in revenue and a loss of $0.46 per share, topping estimates of $18.54 million in revenue and a loss of $0.55 per shareD. E. Shaw.

Hedge fund interest in Exact Sciences Corp (NASDAQ:EXAS) cooled down during the first quarter, as the number of long hedge fund positions dropped to 16 at the end of March, from 20 registered three months earlier. Israel Englander‘s Millennium Management cut its exposure by half and held approximately 1.91 million shares, while Samuel Isaly’s OrbiMed Advisors established a fresh stake in the company and amassed 1.89 million shares by the end of the quarter.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
D. E. Shaw Co. 0 4,901,901 0 4,927,101 4,927,101 5.0%
David E. Shaw 0 4,901,901 0 4,927,101 4,927,101 5.0%
David E. Shaw
David E. Shaw
D E Shaw

Page 1 of 6 – SEC Filing



Washington, D.C. 20549




Under the Securities Exchange Act of 1934


Exact Sciences Corporation

(Name of Issuer)

Common stock, par value $0.01

(Title of Class of Securities)




(CUSIP Number)



July 22, 2016

(Date of Event Which Requires Filing of
this Statement)

Check the following box to designate the rule pursuant to which
the Schedule is filed:

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).

Follow Exact Sciences Corp (NASDAQ:EXAS)
Trade (NASDAQ:EXAS) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.